Earlier this week Celine Halioua (ODF2), founder and CEO of Loyal — a dog longevity biotech startup — announced something truly groundbreaking.
Loyal (ODF2) has earned what they believe to be the FDA’s first-ever formal acceptance that a drug can be developed and approved for lifespan extension.
As Celine says in her announcement; “I started Loyal 4 years ago with the explicit goal to get the first drug FDA approved for lifespan extension itself - no disease, just healthy, longer"..."We can't start selling the drug yet - we need to complete the safety and manufacturing technical sections - but this represents the lions share of the 'existential risk' of both the drug program, and of Loyal AKA - we are doing it!!!”
Laura Deming is a longevity biotech investor with an incredible batting average. 5 of 18 startups she’s backed so far have gone public. She was the first investor in Loyal and had this to say:
"This just dropped - the most important milestone in the history of longevity biotech. put simply, this is the FDA’s first-ever formal acceptance that a drug can be developed and approved to extend lifespan. the longevity field is evolving quickly. No one I know in the field would have said this was possible 5 years ago. Celine got it done in 4. It’s a massive win for both biotech founders and regulators, in establishing a pathway by which drugs (initially for dogs) can get approved for lifespan"
You’re about to listen to an archival interview with Celine just one and a half years into starting Loyal which is now 4 years old. It’s an incredible conversation with interviewer Marshall Kosloff and shows just how much can be accomplished in a few short years.
Congrats to Celine and the entire Loyal team on what is truly an unparalleled milestone.
Are you exploring starting a company we’ve got a program for that?
ODF has helped 1k companies like Loyal which was ODF2 get started and go on to raise over $2B. Applications for our 20th cohort in San Francisco are now . Learn more and apply at beondeck.com
Execs: Systems for Blitzscaling with former Uber Chief Business Officer Emil Michael
Reimagining the News with Goodable's Muhammad Lila
Getting 3D Printing Ready for Primetime with Ahead Wind's Rob Paddock
Democratizing Venture Capital with WeFunder's Jonny Price
Writing the Code of Life with Trevor Martin
Culture Centered Care with Spora’s Dan Miller
Edupreneurship with Virtually's Ish Baid
3D Photo Studios with Colorful's Nik Redl
Trends in Climate Tech with Dr. Clea Kolster of Lowercarbon Capital
ODX Fireside: Fixing the Supply Chain with Flexport's Ryan Petersen
The Future of Wallets with Phantom's Francesco Agosti
The PayPal Diaspora with Jimmy Soni
Optimizing Portfolios for Global Economic Upheaval with Alexander Harmsen
Techno-Optimistic Investing with Minn Kim
When Does Fringe Tech Jump to the Mainstream? A Conversation with Mark Yusko
Execs: Hyperscaling to $1.3 Billion Revenue with Flexport's Ben Braverman
A Back Office for Creators with Passionfroot’s Jen Phan
Democratizing Hedge Funds with Composer's Ben Rollert
Introducing Execs: A Tactical Podcast for Founders in Hypergrowth
2022 Tech Trends
Create your
podcast in
minutes
It is Free
Insight Story: Tech Trends Unpacked
Zero-Shot
Fast Forward by Tomorrow Unlocked: Tech past, tech future
The Unbelivable Truth - Series 1 - 26 including specials and pilot
Lex Fridman Podcast